| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenoproteins | 32 | 2025 | 155 | 10.360 |
Why?
|
| Lenses, Intraocular | 22 | 2025 | 25 | 9.280 |
Why?
|
| Selenium | 23 | 2025 | 155 | 5.650 |
Why?
|
| Phacoemulsification | 12 | 2025 | 19 | 3.650 |
Why?
|
| Biometry | 22 | 2025 | 34 | 3.430 |
Why?
|
| Refraction, Ocular | 20 | 2025 | 48 | 3.410 |
Why?
|
| Cataract | 8 | 2025 | 47 | 3.330 |
Why?
|
| Cornea | 13 | 2025 | 70 | 2.660 |
Why?
|
| Lens, Crystalline | 5 | 2025 | 39 | 2.550 |
Why?
|
| Mice | 64 | 2025 | 6644 | 2.410 |
Why?
|
| T-Lymphocytes | 6 | 2022 | 386 | 2.380 |
Why?
|
| Optics and Photonics | 12 | 2025 | 34 | 2.180 |
Why?
|
| Lymphocyte Activation | 6 | 2024 | 249 | 2.110 |
Why?
|
| Astigmatism | 8 | 2025 | 16 | 2.090 |
Why?
|
| Phospholipids | 3 | 2022 | 70 | 2.050 |
Why?
|
| Animals | 84 | 2026 | 16992 | 1.880 |
Why?
|
| Calpain | 5 | 2021 | 35 | 1.700 |
Why?
|
| Lens Implantation, Intraocular | 11 | 2025 | 16 | 1.640 |
Why?
|
| Calcium Signaling | 5 | 2019 | 107 | 1.590 |
Why?
|
| Mice, Knockout | 18 | 2025 | 1035 | 1.590 |
Why?
|
| Cataract Extraction | 6 | 2025 | 23 | 1.540 |
Why?
|
| Homeostasis | 4 | 2024 | 192 | 1.470 |
Why?
|
| Ethanolamine | 2 | 2021 | 6 | 1.400 |
Why?
|
| Humans | 107 | 2026 | 43102 | 1.370 |
Why?
|
| Mice, Inbred C57BL | 27 | 2025 | 1869 | 1.290 |
Why?
|
| Macrophages | 9 | 2025 | 529 | 1.270 |
Why?
|
| Colitis | 5 | 2024 | 71 | 1.260 |
Why?
|
| Proteome | 6 | 2024 | 152 | 1.250 |
Why?
|
| Corneal Diseases | 3 | 2024 | 11 | 1.240 |
Why?
|
| Lipoylation | 4 | 2016 | 17 | 1.170 |
Why?
|
| Cell Differentiation | 7 | 2024 | 638 | 1.140 |
Why?
|
| Visual Acuity | 7 | 2024 | 111 | 1.130 |
Why?
|
| Ethanolaminephosphotransferase | 3 | 2024 | 4 | 1.100 |
Why?
|
| Tomography, Optical Coherence | 5 | 2024 | 38 | 1.090 |
Why?
|
| Endoplasmic Reticulum | 8 | 2021 | 108 | 1.070 |
Why?
|
| Oligodendroglia | 2 | 2025 | 27 | 1.060 |
Why?
|
| Retrospective Studies | 20 | 2025 | 2544 | 1.040 |
Why?
|
| Disease Models, Animal | 11 | 2024 | 1596 | 0.980 |
Why?
|
| Epithelial Cells | 4 | 2011 | 434 | 0.980 |
Why?
|
| Phagocytosis | 6 | 2025 | 86 | 0.950 |
Why?
|
| Proteomics | 8 | 2024 | 378 | 0.950 |
Why?
|
| Immune System Diseases | 2 | 2018 | 21 | 0.930 |
Why?
|
| Selenocysteine | 3 | 2022 | 58 | 0.920 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 2 | 2015 | 10 | 0.900 |
Why?
|
| Myelin Sheath | 2 | 2025 | 46 | 0.890 |
Why?
|
| Antioxidants | 3 | 2014 | 443 | 0.880 |
Why?
|
| NF-kappa B | 7 | 2024 | 358 | 0.870 |
Why?
|
| Colonic Neoplasms | 2 | 2017 | 223 | 0.850 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 228 | 0.850 |
Why?
|
| Immunoglobulin M | 1 | 2024 | 86 | 0.840 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 189 | 0.840 |
Why?
|
| Lenses | 1 | 2023 | 4 | 0.820 |
Why?
|
| Lipopolysaccharides | 2 | 2024 | 239 | 0.810 |
Why?
|
| Inflammation | 5 | 2018 | 758 | 0.800 |
Why?
|
| Fabaceae | 1 | 2023 | 30 | 0.800 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 148 | 0.760 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2022 | 5 | 0.760 |
Why?
|
| Cell Proliferation | 10 | 2021 | 1455 | 0.760 |
Why?
|
| Calcium | 4 | 2016 | 491 | 0.740 |
Why?
|
| Calcium-Binding Proteins | 2 | 2013 | 81 | 0.730 |
Why?
|
| Algorithms | 2 | 2023 | 509 | 0.710 |
Why?
|
| Asthma | 5 | 2022 | 416 | 0.700 |
Why?
|
| Metabolism | 1 | 2020 | 9 | 0.670 |
Why?
|
| Immunity, Cellular | 2 | 2014 | 74 | 0.670 |
Why?
|
| Stomach Neoplasms | 2 | 2014 | 241 | 0.660 |
Why?
|
| Neoplasms | 4 | 2019 | 1377 | 0.660 |
Why?
|
| Macrophage Activation | 3 | 2015 | 61 | 0.640 |
Why?
|
| Immunity | 2 | 2012 | 61 | 0.630 |
Why?
|
| Transforming Growth Factor alpha | 2 | 2010 | 18 | 0.630 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 196 | 0.630 |
Why?
|
| Blastocyst | 1 | 2020 | 50 | 0.620 |
Why?
|
| Mast Cells | 4 | 2014 | 82 | 0.620 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2015 | 184 | 0.610 |
Why?
|
| Receptors, IgG | 3 | 2016 | 53 | 0.600 |
Why?
|
| Cell Movement | 8 | 2021 | 655 | 0.600 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2010 | 11 | 0.600 |
Why?
|
| Substance P | 2 | 2010 | 26 | 0.590 |
Why?
|
| Ovarian Neoplasms | 4 | 2016 | 415 | 0.590 |
Why?
|
| Immune System | 1 | 2018 | 41 | 0.570 |
Why?
|
| Phosphatidylethanolamines | 3 | 2024 | 17 | 0.560 |
Why?
|
| Colon | 4 | 2024 | 120 | 0.560 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 300 | 0.560 |
Why?
|
| Acyltransferases | 2 | 2015 | 22 | 0.560 |
Why?
|
| Cardiovascular System | 2 | 2016 | 37 | 0.550 |
Why?
|
| Mesothelioma | 3 | 2015 | 148 | 0.550 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2016 | 185 | 0.540 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2015 | 34 | 0.540 |
Why?
|
| Vaccines, DNA | 2 | 2015 | 24 | 0.540 |
Why?
|
| Cancer Vaccines | 2 | 2015 | 30 | 0.530 |
Why?
|
| Interferon-gamma | 4 | 2015 | 269 | 0.520 |
Why?
|
| Selenoprotein P | 2 | 2007 | 45 | 0.510 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 237 | 0.510 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2016 | 14 | 0.500 |
Why?
|
| Diet | 5 | 2014 | 826 | 0.500 |
Why?
|
| Antineoplastic Agents | 3 | 2025 | 1019 | 0.490 |
Why?
|
| Acetylation | 1 | 2016 | 107 | 0.490 |
Why?
|
| Male | 29 | 2025 | 23409 | 0.490 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 98 | 0.490 |
Why?
|
| Lung Neoplasms | 5 | 2025 | 495 | 0.490 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2014 | 91 | 0.480 |
Why?
|
| Mannose | 3 | 2024 | 32 | 0.470 |
Why?
|
| MicroRNAs | 1 | 2022 | 518 | 0.470 |
Why?
|
| Stress, Physiological | 2 | 2014 | 172 | 0.470 |
Why?
|
| Intestinal Mucosa | 4 | 2024 | 134 | 0.460 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2020 | 102 | 0.460 |
Why?
|
| Peptide Fragments | 2 | 2016 | 307 | 0.450 |
Why?
|
| Refractive Errors | 3 | 2024 | 28 | 0.450 |
Why?
|
| Oligopeptides | 1 | 2015 | 109 | 0.440 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 291 | 0.430 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2014 | 279 | 0.430 |
Why?
|
| Up-Regulation | 4 | 2024 | 536 | 0.420 |
Why?
|
| Models, Biological | 5 | 2022 | 712 | 0.410 |
Why?
|
| Female | 28 | 2025 | 24698 | 0.410 |
Why?
|
| Nanoparticles | 4 | 2025 | 460 | 0.410 |
Why?
|
| Micronutrients | 1 | 2014 | 45 | 0.410 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 307 | 0.410 |
Why?
|
| Gastrointestinal Diseases | 1 | 2014 | 51 | 0.400 |
Why?
|
| Oxidative Stress | 4 | 2024 | 1003 | 0.390 |
Why?
|
| Lymph Nodes | 6 | 2021 | 74 | 0.390 |
Why?
|
| Plasmids | 2 | 2014 | 244 | 0.390 |
Why?
|
| Arsenic | 3 | 2025 | 155 | 0.380 |
Why?
|
| Glutathione Peroxidase | 3 | 2024 | 112 | 0.380 |
Why?
|
| Mass Spectrometry | 8 | 2024 | 280 | 0.380 |
Why?
|
| Oxidation-Reduction | 5 | 2022 | 457 | 0.370 |
Why?
|
| Neoplasms, Experimental | 1 | 2012 | 38 | 0.370 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2019 | 241 | 0.370 |
Why?
|
| Tuberculosis | 2 | 2025 | 78 | 0.360 |
Why?
|
| Ethanolamines | 2 | 2022 | 9 | 0.360 |
Why?
|
| Blotting, Western | 6 | 2017 | 883 | 0.360 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 20 | 0.360 |
Why?
|
| Organoselenium Compounds | 2 | 2025 | 9 | 0.360 |
Why?
|
| Rats | 10 | 2025 | 3735 | 0.360 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2011 | 57 | 0.350 |
Why?
|
| Toll-Like Receptors | 1 | 2011 | 51 | 0.350 |
Why?
|
| Myocardium | 2 | 2011 | 263 | 0.350 |
Why?
|
| Dendritic Cells | 4 | 2021 | 132 | 0.350 |
Why?
|
| Lymphotoxin-alpha | 1 | 2011 | 4 | 0.340 |
Why?
|
| Dietary Supplements | 2 | 2010 | 213 | 0.340 |
Why?
|
| Cell Migration Inhibition | 1 | 2011 | 5 | 0.340 |
Why?
|
| Reproducibility of Results | 8 | 2026 | 1081 | 0.340 |
Why?
|
| Wound Healing | 2 | 2011 | 88 | 0.340 |
Why?
|
| Mice, Inbred BALB C | 6 | 2015 | 694 | 0.340 |
Why?
|
| Cell Line | 9 | 2016 | 1410 | 0.330 |
Why?
|
| RNA, Messenger | 7 | 2015 | 1271 | 0.320 |
Why?
|
| Lung | 4 | 2025 | 492 | 0.320 |
Why?
|
| Cross Infection | 2 | 2020 | 48 | 0.320 |
Why?
|
| Cell Line, Tumor | 10 | 2019 | 2676 | 0.320 |
Why?
|
| Carbachol | 1 | 2009 | 18 | 0.320 |
Why?
|
| Sulfhydryl Compounds | 1 | 2010 | 51 | 0.320 |
Why?
|
| Sepsis | 2 | 2021 | 90 | 0.320 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2009 | 13 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 968 | 0.310 |
Why?
|
| Fibroblasts | 2 | 2020 | 281 | 0.310 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 665 | 0.310 |
Why?
|
| Sensation | 1 | 2009 | 36 | 0.310 |
Why?
|
| Monte Carlo Method | 3 | 2024 | 64 | 0.310 |
Why?
|
| Transfection | 3 | 2015 | 532 | 0.300 |
Why?
|
| Immunity, Innate | 3 | 2018 | 171 | 0.300 |
Why?
|
| Apoptosis | 8 | 2021 | 1568 | 0.300 |
Why?
|
| Peptides | 1 | 2012 | 372 | 0.290 |
Why?
|
| Amino Acid Sequence | 9 | 2020 | 1180 | 0.290 |
Why?
|
| Nitric Oxide | 1 | 2011 | 386 | 0.290 |
Why?
|
| Aged | 13 | 2025 | 8214 | 0.290 |
Why?
|
| Leukocyte Elastase | 3 | 2024 | 12 | 0.280 |
Why?
|
| Central Nervous System | 2 | 2022 | 152 | 0.270 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 515 | 0.270 |
Why?
|
| Endothelium, Vascular | 3 | 2019 | 263 | 0.270 |
Why?
|
| Lymphocyte Subsets | 1 | 2007 | 21 | 0.270 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 15 | 0.270 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 749 | 0.270 |
Why?
|
| Cells, Cultured | 9 | 2020 | 1621 | 0.270 |
Why?
|
| Flow Cytometry | 2 | 2014 | 411 | 0.270 |
Why?
|
| Lipids | 2 | 2025 | 256 | 0.260 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 146 | 0.260 |
Why?
|
| Cytokines | 4 | 2015 | 678 | 0.260 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 34 | 0.260 |
Why?
|
| Selenomethionine | 2 | 2017 | 13 | 0.250 |
Why?
|
| Bone Marrow Cells | 3 | 2014 | 79 | 0.250 |
Why?
|
| Brain | 4 | 2024 | 1472 | 0.240 |
Why?
|
| Anterior Chamber | 2 | 2024 | 12 | 0.240 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 1070 | 0.240 |
Why?
|
| Caseins | 2 | 2020 | 15 | 0.240 |
Why?
|
| Alzheimer Disease | 3 | 2020 | 1001 | 0.240 |
Why?
|
| Cell Nucleus | 3 | 2017 | 383 | 0.240 |
Why?
|
| Down-Regulation | 4 | 2017 | 456 | 0.230 |
Why?
|
| Sepharose | 1 | 2025 | 17 | 0.230 |
Why?
|
| Lactoferrin | 1 | 2025 | 9 | 0.230 |
Why?
|
| Annexin A2 | 2 | 2016 | 6 | 0.230 |
Why?
|
| Disease Progression | 3 | 2019 | 667 | 0.230 |
Why?
|
| Amyloid | 2 | 2020 | 65 | 0.230 |
Why?
|
| Transcortin | 1 | 2024 | 1 | 0.230 |
Why?
|
| Phosphatidylserines | 1 | 2005 | 22 | 0.230 |
Why?
|
| Asparagine | 1 | 2024 | 9 | 0.220 |
Why?
|
| Temperature | 3 | 2021 | 313 | 0.220 |
Why?
|
| Cross-Sectional Studies | 8 | 2025 | 3156 | 0.220 |
Why?
|
| HCT116 Cells | 2 | 2017 | 40 | 0.220 |
Why?
|
| Retroviridae Infections | 1 | 2024 | 4 | 0.220 |
Why?
|
| Signal Transduction | 6 | 2017 | 2157 | 0.220 |
Why?
|
| Shock, Septic | 1 | 2024 | 20 | 0.220 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 132 | 0.220 |
Why?
|
| Plasma Cells | 1 | 2024 | 12 | 0.220 |
Why?
|
| RNA, Viral | 2 | 2016 | 321 | 0.220 |
Why?
|
| Multiprotein Complexes | 2 | 2015 | 56 | 0.220 |
Why?
|
| Nomograms | 1 | 2024 | 14 | 0.220 |
Why?
|
| Enzyme Activation | 4 | 2014 | 462 | 0.220 |
Why?
|
| Molecular Biology | 2 | 2015 | 47 | 0.220 |
Why?
|
| Fluorouracil | 1 | 2024 | 47 | 0.210 |
Why?
|
| Prognosis | 4 | 2021 | 861 | 0.210 |
Why?
|
| Phospholipid Ethers | 1 | 2024 | 4 | 0.210 |
Why?
|
| Culicidae | 1 | 2004 | 26 | 0.210 |
Why?
|
| Methionine Sulfoxide Reductases | 2 | 2014 | 2 | 0.210 |
Why?
|
| Plasmalogens | 1 | 2024 | 3 | 0.210 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 94 | 0.210 |
Why?
|
| Eyeglasses | 1 | 2024 | 22 | 0.210 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2024 | 6 | 0.210 |
Why?
|
| Transgenes | 2 | 2015 | 65 | 0.210 |
Why?
|
| Drug Carriers | 1 | 2025 | 174 | 0.210 |
Why?
|
| Genetic Vectors | 2 | 2015 | 165 | 0.210 |
Why?
|
| Middle Aged | 12 | 2025 | 12222 | 0.210 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 2024 | 32 | 0.210 |
Why?
|
| Eye, Artificial | 1 | 2023 | 1 | 0.210 |
Why?
|
| Zinc | 1 | 2025 | 131 | 0.210 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2025 | 92 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 3 | 2025 | 209 | 0.200 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2025 | 109 | 0.200 |
Why?
|
| Lipid Peroxidation | 1 | 2024 | 140 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 652 | 0.200 |
Why?
|
| HT29 Cells | 2 | 2015 | 60 | 0.200 |
Why?
|
| Phosphorylation | 6 | 2016 | 986 | 0.200 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 436 | 0.200 |
Why?
|
| Iron | 1 | 2025 | 251 | 0.200 |
Why?
|
| West Nile virus | 1 | 2004 | 78 | 0.200 |
Why?
|
| Refractometry | 1 | 2023 | 16 | 0.200 |
Why?
|
| Police | 1 | 2022 | 17 | 0.190 |
Why?
|
| Forkhead Transcription Factors | 2 | 2022 | 78 | 0.190 |
Why?
|
| Biology | 1 | 2023 | 20 | 0.190 |
Why?
|
| Cytidine Diphosphate | 1 | 2022 | 3 | 0.190 |
Why?
|
| Schools, Medical | 2 | 2015 | 208 | 0.190 |
Why?
|
| Cooperative Behavior | 1 | 2025 | 269 | 0.190 |
Why?
|
| Ovalbumin | 3 | 2007 | 47 | 0.190 |
Why?
|
| Phosphotransferases | 1 | 2022 | 36 | 0.190 |
Why?
|
| Blood Pressure | 1 | 2026 | 666 | 0.190 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2022 | 3 | 0.190 |
Why?
|
| Interleukin-17 | 1 | 2022 | 53 | 0.190 |
Why?
|
| Tomography | 1 | 2022 | 9 | 0.180 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2022 | 14 | 0.180 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2022 | 27 | 0.180 |
Why?
|
| Serine | 2 | 2016 | 79 | 0.180 |
Why?
|
| Occupational Exposure | 1 | 2022 | 91 | 0.180 |
Why?
|
| Protein Multimerization | 2 | 2020 | 115 | 0.180 |
Why?
|
| Hypothermia | 1 | 2021 | 13 | 0.180 |
Why?
|
| Organoids | 1 | 2022 | 37 | 0.180 |
Why?
|
| Endothelial Cells | 1 | 2025 | 329 | 0.180 |
Why?
|
| Regression Analysis | 1 | 2023 | 490 | 0.180 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 82 | 0.180 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 1542 | 0.180 |
Why?
|
| Vision Tests | 1 | 2021 | 5 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 69 | 0.170 |
Why?
|
| Postoperative Period | 1 | 2021 | 33 | 0.170 |
Why?
|
| Fever | 1 | 2021 | 62 | 0.170 |
Why?
|
| Chemokine CCL21 | 1 | 2021 | 14 | 0.170 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 116 | 0.170 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2021 | 19 | 0.170 |
Why?
|
| Air Pollution | 1 | 2022 | 87 | 0.170 |
Why?
|
| STAT6 Transcription Factor | 2 | 2013 | 17 | 0.170 |
Why?
|
| Lipogenesis | 1 | 2021 | 19 | 0.170 |
Why?
|
| Receptors, CCR | 1 | 2021 | 26 | 0.170 |
Why?
|
| Latent Tuberculosis | 1 | 2020 | 4 | 0.170 |
Why?
|
| Air Conditioning | 1 | 2020 | 2 | 0.170 |
Why?
|
| Ventilation | 1 | 2020 | 4 | 0.170 |
Why?
|
| Heating | 1 | 2020 | 6 | 0.170 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2020 | 12 | 0.170 |
Why?
|
| Factor XIa | 1 | 2020 | 4 | 0.170 |
Why?
|
| Respiration Disorders | 1 | 2020 | 9 | 0.160 |
Why?
|
| Glycolysis | 1 | 2021 | 71 | 0.160 |
Why?
|
| Embryo Loss | 1 | 2020 | 4 | 0.160 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 22 | 0.160 |
Why?
|
| Jurkat Cells | 4 | 2016 | 87 | 0.160 |
Why?
|
| Environment Design | 1 | 2020 | 32 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 74 | 0.160 |
Why?
|
| Metabolomics | 1 | 2021 | 95 | 0.160 |
Why?
|
| Homozygote | 1 | 2020 | 77 | 0.160 |
Why?
|
| Embryo Implantation | 1 | 2020 | 31 | 0.160 |
Why?
|
| Sunlight | 1 | 2020 | 48 | 0.160 |
Why?
|
| Drug Delivery Systems | 2 | 2025 | 277 | 0.160 |
Why?
|
| Prosthesis Design | 3 | 2024 | 47 | 0.160 |
Why?
|
| Seasons | 1 | 2020 | 139 | 0.160 |
Why?
|
| Gene Deletion | 1 | 2020 | 168 | 0.150 |
Why?
|
| Embryonic Development | 1 | 2020 | 83 | 0.150 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 167 | 0.150 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2020 | 135 | 0.150 |
Why?
|
| Hospitals | 1 | 2020 | 117 | 0.150 |
Why?
|
| Antibody Specificity | 2 | 2018 | 76 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2025 | 532 | 0.150 |
Why?
|
| Phenotype | 1 | 2022 | 780 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2025 | 502 | 0.150 |
Why?
|
| Capillary Permeability | 1 | 2019 | 36 | 0.150 |
Why?
|
| Glycoproteins | 3 | 2022 | 125 | 0.150 |
Why?
|
| Chromatography, Liquid | 3 | 2019 | 182 | 0.150 |
Why?
|
| Animals, Newborn | 1 | 2020 | 352 | 0.150 |
Why?
|
| Dextran Sulfate | 2 | 2016 | 19 | 0.150 |
Why?
|
| Liposomes | 2 | 2013 | 132 | 0.150 |
Why?
|
| Students | 1 | 2025 | 626 | 0.150 |
Why?
|
| Mice, Nude | 2 | 2017 | 408 | 0.150 |
Why?
|
| Synapses | 1 | 2020 | 185 | 0.150 |
Why?
|
| Cysteine | 2 | 2020 | 103 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 347 | 0.140 |
Why?
|
| Tumor Escape | 1 | 2018 | 17 | 0.140 |
Why?
|
| O Antigens | 1 | 2018 | 7 | 0.140 |
Why?
|
| Klebsiella pneumoniae | 1 | 2018 | 26 | 0.140 |
Why?
|
| Hospitalization | 1 | 2022 | 485 | 0.140 |
Why?
|
| Leukocytes | 1 | 2018 | 80 | 0.140 |
Why?
|
| Cystadenocarcinoma, Serous | 2 | 2015 | 44 | 0.140 |
Why?
|
| Antibodies, Bacterial | 1 | 2018 | 117 | 0.140 |
Why?
|
| Chorioallantoic Membrane | 1 | 2017 | 11 | 0.140 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 10 | 0.130 |
Why?
|
| Integrin beta3 | 1 | 2017 | 7 | 0.130 |
Why?
|
| Th2 Cells | 2 | 2007 | 62 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 2 | 2010 | 216 | 0.130 |
Why?
|
| Computer Simulation | 3 | 2024 | 408 | 0.130 |
Why?
|
| Allergens | 2 | 2007 | 65 | 0.130 |
Why?
|
| Streptococcus pneumoniae | 1 | 2017 | 34 | 0.130 |
Why?
|
| Pneumococcal Infections | 1 | 2017 | 33 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 2853 | 0.130 |
Why?
|
| Actinin | 1 | 2016 | 5 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 296 | 0.130 |
Why?
|
| Colitis, Ulcerative | 2 | 2024 | 70 | 0.130 |
Why?
|
| Protein Binding | 3 | 2016 | 1082 | 0.130 |
Why?
|
| Phospholipase C beta | 1 | 2016 | 2 | 0.130 |
Why?
|
| Chemical Fractionation | 1 | 2016 | 14 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2017 | 368 | 0.130 |
Why?
|
| Deoxycytidine | 1 | 2017 | 38 | 0.130 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 9 | 0.130 |
Why?
|
| Carboplatin | 1 | 2016 | 20 | 0.130 |
Why?
|
| Spirulina | 1 | 2016 | 1 | 0.120 |
Why?
|
| Phycocyanin | 1 | 2016 | 2 | 0.120 |
Why?
|
| Databases, Protein | 1 | 2016 | 54 | 0.120 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2016 | 35 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 1 | 2016 | 29 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2017 | 72 | 0.120 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 139 | 0.120 |
Why?
|
| Pyrrolidines | 1 | 2016 | 31 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2026 | 127 | 0.120 |
Why?
|
| Receptors, Steroid | 1 | 2016 | 38 | 0.120 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 374 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 62 | 0.120 |
Why?
|
| Imidazoles | 1 | 2016 | 142 | 0.120 |
Why?
|
| Azoxymethane | 1 | 2015 | 9 | 0.120 |
Why?
|
| I-kappa B Proteins | 1 | 2015 | 36 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 166 | 0.120 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 60 | 0.120 |
Why?
|
| Hepacivirus | 1 | 2016 | 74 | 0.120 |
Why?
|
| tau Proteins | 1 | 2017 | 186 | 0.120 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 40 | 0.120 |
Why?
|
| RNA | 2 | 2009 | 266 | 0.120 |
Why?
|
| Endometrial Neoplasms | 1 | 2016 | 79 | 0.120 |
Why?
|
| Transketolase | 1 | 2015 | 2 | 0.120 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2016 | 53 | 0.110 |
Why?
|
| Peritoneal Neoplasms | 1 | 2015 | 18 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 159 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 133 | 0.110 |
Why?
|
| Thapsigargin | 1 | 2014 | 7 | 0.110 |
Why?
|
| Granzymes | 1 | 2015 | 19 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 187 | 0.110 |
Why?
|
| src Homology Domains | 1 | 2014 | 14 | 0.110 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2014 | 7 | 0.110 |
Why?
|
| Immunodominant Epitopes | 1 | 2015 | 29 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2017 | 243 | 0.110 |
Why?
|
| Antibody Formation | 1 | 2015 | 76 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 32 | 0.110 |
Why?
|
| Cell Biology | 1 | 2014 | 13 | 0.110 |
Why?
|
| Immunization | 1 | 2015 | 94 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 117 | 0.110 |
Why?
|
| beta-Endorphin | 1 | 2014 | 17 | 0.110 |
Why?
|
| Pregnancy | 1 | 2020 | 1772 | 0.110 |
Why?
|
| Hepatitis C | 1 | 2016 | 139 | 0.110 |
Why?
|
| Uncertainty | 2 | 2024 | 32 | 0.110 |
Why?
|
| Particle Size | 3 | 2025 | 272 | 0.110 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2014 | 14 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 65 | 0.110 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2014 | 4 | 0.110 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 74 | 0.110 |
Why?
|
| Haptoglobins | 1 | 2014 | 10 | 0.110 |
Why?
|
| Corneal Topography | 2 | 2024 | 27 | 0.110 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2014 | 7 | 0.110 |
Why?
|
| RNA-Binding Proteins | 2 | 2006 | 161 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 186 | 0.110 |
Why?
|
| Clusterin | 1 | 2014 | 9 | 0.110 |
Why?
|
| Sensory Receptor Cells | 1 | 2014 | 34 | 0.110 |
Why?
|
| Cattle | 3 | 2025 | 498 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2007 | 206 | 0.100 |
Why?
|
| Cell Communication | 2 | 2013 | 114 | 0.100 |
Why?
|
| Spleen | 3 | 2015 | 204 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 55 | 0.100 |
Why?
|
| Kidney | 1 | 2016 | 372 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 154 | 0.100 |
Why?
|
| Serum Albumin | 1 | 2014 | 59 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2014 | 148 | 0.100 |
Why?
|
| Freeze Drying | 1 | 2013 | 29 | 0.100 |
Why?
|
| ROC Curve | 1 | 2014 | 159 | 0.100 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2013 | 22 | 0.100 |
Why?
|
| Methionine | 1 | 2013 | 27 | 0.100 |
Why?
|
| Virus Replication | 1 | 2016 | 318 | 0.100 |
Why?
|
| Mixed Function Oxygenases | 1 | 2013 | 31 | 0.100 |
Why?
|
| Research | 1 | 2015 | 181 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1604 | 0.100 |
Why?
|
| Foam Cells | 1 | 2013 | 16 | 0.100 |
Why?
|
| Milk | 2 | 2025 | 56 | 0.100 |
Why?
|
| Mutation | 3 | 2017 | 1177 | 0.100 |
Why?
|
| Oxidoreductases | 1 | 2013 | 79 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1285 | 0.100 |
Why?
|
| Dogs | 2 | 2026 | 204 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 247 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 95 | 0.100 |
Why?
|
| Actins | 1 | 2013 | 164 | 0.090 |
Why?
|
| Protein Transport | 1 | 2013 | 296 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 116 | 0.090 |
Why?
|
| Microtomy | 1 | 2012 | 9 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 458 | 0.090 |
Why?
|
| Peptide Mapping | 1 | 2012 | 20 | 0.090 |
Why?
|
| Observer Variation | 1 | 2012 | 59 | 0.090 |
Why?
|
| Calibration | 1 | 2012 | 63 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 595 | 0.090 |
Why?
|
| Glycosylation | 2 | 2024 | 113 | 0.090 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 52 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 104 | 0.090 |
Why?
|
| Cystic Fibrosis | 2 | 2002 | 28 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2025 | 1766 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 53 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2014 | 321 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 75 | 0.090 |
Why?
|
| Hypertrophy | 1 | 2011 | 34 | 0.090 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 47 | 0.090 |
Why?
|
| Nanostructures | 1 | 2013 | 161 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 128 | 0.090 |
Why?
|
| Carcinoma | 1 | 2012 | 108 | 0.090 |
Why?
|
| Universities | 1 | 2015 | 559 | 0.090 |
Why?
|
| Peritonitis | 1 | 2011 | 11 | 0.090 |
Why?
|
| Butyrates | 1 | 2011 | 34 | 0.080 |
Why?
|
| Receptors, Peptide | 1 | 2011 | 24 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2013 | 169 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2020 | 384 | 0.080 |
Why?
|
| Mannose-Binding Lectin | 1 | 2010 | 6 | 0.080 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2010 | 32 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2013 | 273 | 0.080 |
Why?
|
| Ligands | 1 | 2011 | 388 | 0.080 |
Why?
|
| Bromodeoxyuridine | 1 | 2009 | 25 | 0.080 |
Why?
|
| DNA | 2 | 2010 | 592 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2010 | 91 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2011 | 195 | 0.080 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 2017 | 78 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2010 | 71 | 0.080 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2009 | 2 | 0.080 |
Why?
|
| Phosphotyrosine | 1 | 2009 | 23 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 21 | 0.070 |
Why?
|
| Phosphoserine | 1 | 2009 | 21 | 0.070 |
Why?
|
| Peptide Elongation Factors | 2 | 2006 | 11 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 201 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2009 | 283 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2011 | 561 | 0.070 |
Why?
|
| Adult | 6 | 2020 | 13872 | 0.070 |
Why?
|
| Endopeptidase K | 1 | 2008 | 4 | 0.070 |
Why?
|
| Base Sequence | 2 | 2014 | 983 | 0.070 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 49 | 0.070 |
Why?
|
| Trypsin | 1 | 2008 | 40 | 0.070 |
Why?
|
| Monocytes | 2 | 2024 | 277 | 0.070 |
Why?
|
| Caco-2 Cells | 1 | 2008 | 64 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2017 | 299 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 18 | 0.070 |
Why?
|
| Caveolin 1 | 1 | 2007 | 33 | 0.070 |
Why?
|
| Antibodies | 1 | 2008 | 144 | 0.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 55 | 0.070 |
Why?
|
| Thiazoles | 1 | 2008 | 76 | 0.070 |
Why?
|
| Immunoglobulin E | 1 | 2007 | 61 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 97 | 0.070 |
Why?
|
| Proteins | 1 | 2009 | 382 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2007 | 240 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2008 | 204 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2008 | 226 | 0.060 |
Why?
|
| Time Factors | 2 | 2008 | 1857 | 0.060 |
Why?
|
| Telemetry | 1 | 2026 | 14 | 0.060 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 2 | 2002 | 4 | 0.060 |
Why?
|
| Testis | 1 | 2007 | 207 | 0.060 |
Why?
|
| Acrylic Resins | 1 | 2025 | 13 | 0.060 |
Why?
|
| Cell Survival | 3 | 2016 | 945 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2025 | 25 | 0.060 |
Why?
|
| Chick Embryo | 2 | 2017 | 79 | 0.060 |
Why?
|
| Cations | 1 | 2025 | 50 | 0.060 |
Why?
|
| Porosity | 1 | 2025 | 43 | 0.060 |
Why?
|
| Codon | 1 | 2005 | 39 | 0.060 |
Why?
|
| Gelatin | 2 | 2017 | 17 | 0.060 |
Why?
|
| RNA, Transfer | 1 | 2005 | 29 | 0.060 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 35 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2025 | 159 | 0.060 |
Why?
|
| Hybridomas | 1 | 2005 | 24 | 0.060 |
Why?
|
| Multigene Family | 1 | 2005 | 105 | 0.060 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 36 | 0.060 |
Why?
|
| Immune Sera | 1 | 2005 | 56 | 0.060 |
Why?
|
| Anterior Eye Segment | 1 | 2025 | 9 | 0.060 |
Why?
|
| Germinal Center | 1 | 2005 | 12 | 0.060 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2017 | 97 | 0.060 |
Why?
|
| Adoptive Transfer | 1 | 2005 | 53 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 512 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2005 | 50 | 0.060 |
Why?
|
| Cell Adhesion | 2 | 2017 | 238 | 0.060 |
Why?
|
| Retroviridae | 1 | 2024 | 25 | 0.050 |
Why?
|
| Pseudophakia | 1 | 2024 | 3 | 0.050 |
Why?
|
| Preoperative Period | 1 | 2024 | 9 | 0.050 |
Why?
|
| Erythrocytes | 2 | 2022 | 126 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 60 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2005 | 169 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 89 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2004 | 30 | 0.050 |
Why?
|
| Anopheles | 1 | 2004 | 21 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2025 | 120 | 0.050 |
Why?
|
| Lymphangiogenesis | 1 | 2024 | 3 | 0.050 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 5 | 0.050 |
Why?
|
| Cell Death | 1 | 2025 | 278 | 0.050 |
Why?
|
| Chitosan | 1 | 2024 | 53 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2024 | 35 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2015 | 109 | 0.050 |
Why?
|
| Vibrissae | 1 | 2024 | 32 | 0.050 |
Why?
|
| Aedes | 1 | 2004 | 43 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 294 | 0.050 |
Why?
|
| Oceania | 1 | 2023 | 3 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2004 | 69 | 0.050 |
Why?
|
| Calcinosis | 1 | 2024 | 62 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2026 | 287 | 0.050 |
Why?
|
| Asia | 1 | 2023 | 98 | 0.050 |
Why?
|
| Research Personnel | 1 | 2025 | 206 | 0.050 |
Why?
|
| Berlin | 1 | 2022 | 2 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 165 | 0.050 |
Why?
|
| Aging | 1 | 2008 | 783 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2022 | 45 | 0.050 |
Why?
|
| Complement C1q | 1 | 2002 | 2 | 0.050 |
Why?
|
| Viral Load | 1 | 2024 | 348 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2002 | 5 | 0.050 |
Why?
|
| Calreticulin | 1 | 2002 | 8 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 934 | 0.050 |
Why?
|
| Cross Reactions | 2 | 2018 | 87 | 0.050 |
Why?
|
| Germany | 1 | 2022 | 26 | 0.050 |
Why?
|
| Nitrogen Dioxide | 1 | 2022 | 17 | 0.050 |
Why?
|
| Bronchiectasis | 1 | 2002 | 13 | 0.050 |
Why?
|
| Ozone | 1 | 2022 | 26 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2024 | 189 | 0.050 |
Why?
|
| Respiratory System | 1 | 2002 | 31 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 220 | 0.040 |
Why?
|
| Urban Health | 1 | 2022 | 101 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2022 | 63 | 0.040 |
Why?
|
| Lead | 1 | 2022 | 100 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2022 | 83 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2022 | 190 | 0.040 |
Why?
|
| Tuberculin Test | 1 | 2020 | 3 | 0.040 |
Why?
|
| Necrosis | 1 | 2020 | 54 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2020 | 13 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2020 | 29 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2022 | 587 | 0.040 |
Why?
|
| Disulfides | 1 | 2020 | 95 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 72 | 0.040 |
Why?
|
| Biological Availability | 1 | 2020 | 116 | 0.040 |
Why?
|
| Stroke | 1 | 2024 | 340 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 260 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 131 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2013 | 168 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2024 | 1600 | 0.040 |
Why?
|
| United States | 2 | 2025 | 5205 | 0.040 |
Why?
|
| Hypertension | 1 | 2026 | 835 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2020 | 246 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 506 | 0.040 |
Why?
|
| Hawaii | 2 | 2015 | 2011 | 0.040 |
Why?
|
| Macrophages, Alveolar | 3 | 2002 | 34 | 0.030 |
Why?
|
| Serotyping | 1 | 2017 | 37 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2017 | 6 | 0.030 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2017 | 36 | 0.030 |
Why?
|
| Adolescent | 3 | 2020 | 6081 | 0.030 |
Why?
|
| Ulva | 1 | 2017 | 6 | 0.030 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2017 | 35 | 0.030 |
Why?
|
| Viscosity | 1 | 2017 | 46 | 0.030 |
Why?
|
| Macrolides | 1 | 2017 | 14 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2017 | 66 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1078 | 0.030 |
Why?
|
| Presenilin-1 | 1 | 2017 | 28 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 92 | 0.030 |
Why?
|
| Aerosols | 1 | 2017 | 54 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 32 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 74 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 51 | 0.030 |
Why?
|
| Maze Learning | 1 | 2017 | 113 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 81 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 95 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2016 | 42 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 306 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 60 | 0.030 |
Why?
|
| Reaction Time | 1 | 2017 | 157 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 158 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2017 | 70 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 97 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 87 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1759 | 0.030 |
Why?
|
| Autophagy | 1 | 2017 | 140 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 206 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 423 | 0.030 |
Why?
|
| Blood | 1 | 2015 | 37 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2016 | 165 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 114 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 127 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 458 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 209 | 0.030 |
Why?
|
| Education, Graduate | 1 | 2014 | 31 | 0.030 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2014 | 12 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 2014 | 25 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 386 | 0.030 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2014 | 17 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 29 | 0.030 |
Why?
|
| HIV Infections | 1 | 2008 | 2586 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 93 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2014 | 74 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 355 | 0.030 |
Why?
|
| Europe | 1 | 2014 | 115 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 58 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 508 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 290 | 0.030 |
Why?
|
| Powder Diffraction | 1 | 2013 | 2 | 0.030 |
Why?
|
| RNA Stability | 1 | 2013 | 28 | 0.030 |
Why?
|
| Nanocapsules | 1 | 2013 | 19 | 0.030 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 95 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2013 | 104 | 0.030 |
Why?
|
| Fowlpox virus | 1 | 2013 | 2 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 53 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 72 | 0.020 |
Why?
|
| Nanomedicine | 1 | 2013 | 52 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 67 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2013 | 127 | 0.020 |
Why?
|
| Mitochondria | 1 | 2016 | 523 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 1723 | 0.020 |
Why?
|
| Child | 1 | 2020 | 3443 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 1067 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 465 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 701 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 5080 | 0.020 |
Why?
|
| Decision Making | 1 | 2014 | 249 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2013 | 144 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2011 | 18 | 0.020 |
Why?
|
| Fatty Acids, Volatile | 1 | 2011 | 8 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2011 | 13 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 21 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 57 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 70 | 0.020 |
Why?
|
| Vaccination | 1 | 2013 | 355 | 0.020 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2010 | 9 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 227 | 0.020 |
Why?
|
| Rheumatic Diseases | 1 | 2010 | 12 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1263 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2009 | 14 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 257 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 91 | 0.020 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2008 | 6 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2007 | 6 | 0.020 |
Why?
|
| Benzothiazoles | 1 | 2008 | 26 | 0.020 |
Why?
|
| Interleukins | 1 | 2007 | 40 | 0.020 |
Why?
|
| Pulmonary Fibrosis | 1 | 2007 | 38 | 0.020 |
Why?
|
| Casein Kinase II | 1 | 2007 | 17 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 800 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 184 | 0.020 |
Why?
|
| Swine | 1 | 2007 | 212 | 0.020 |
Why?
|
| Nuclear Export Signals | 1 | 2006 | 2 | 0.020 |
Why?
|
| Genetic Code | 1 | 2006 | 7 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2006 | 15 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 60 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2006 | 154 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 267 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 92 | 0.010 |
Why?
|
| Proteolipids | 1 | 2002 | 4 | 0.010 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2002 | 3 | 0.010 |
Why?
|
| Cathepsin G | 1 | 2002 | 3 | 0.010 |
Why?
|
| Cathepsins | 1 | 2002 | 9 | 0.010 |
Why?
|
| Sputum | 1 | 2002 | 22 | 0.010 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2002 | 12 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2002 | 48 | 0.010 |
Why?
|
| Neutrophils | 1 | 2002 | 145 | 0.010 |
Why?
|
| Pulmonary Surfactants | 1 | 2002 | 33 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 735 | 0.010 |
Why?
|